O	0	7	Diverse	Diverse	JJ	B-NP
B-Cell	8	12	cell	cell	NN	I-NP
O	13	22	signaling	signaling	NN	I-NP
O	23	29	events	event	NNS	I-NP
O	30	39	modulated	modulate	VBN	B-VP
O	40	42	by	by	IN	B-PP
O	43	51	perlecan	perlecan	NN	B-NP
O	51	52	.	.	.	O

O	53	61	Perlecan	Perlecan	NNP	B-NP
O	62	64	is	be	VBZ	B-VP
O	65	66	a	a	DT	B-NP
O	67	77	ubiquitous	ubiquitous	JJ	I-NP
B-Immaterial_anatomical_entity	78	90	pericellular	pericellular	JJ	I-NP
O	91	103	proteoglycan	proteoglycan	NN	I-NP
O	104	111	ideally	ideally	RB	B-VP
O	112	118	placed	place	VBN	I-VP
O	119	121	to	to	TO	I-VP
O	122	129	mediate	mediate	VB	I-VP
B-Cell	130	134	cell	cell	NN	B-NP
O	135	144	signaling	signaling	NN	I-NP
O	145	151	events	event	NNS	I-NP
O	152	163	controlling	control	VBG	B-VP
O	164	173	migration	migration	NN	B-NP
O	173	174	,	,	,	O
O	175	188	proliferation	proliferation	NN	B-NP
O	188	189	,	,	,	O
O	190	193	and	and	CC	O
O	194	209	differentiation	differentiation	NN	B-NP
O	209	210	.	.	.	O

O	211	214	Its	Its	PRP$	B-NP
O	215	222	control	control	NN	I-NP
O	223	225	of	of	IN	B-PP
O	226	232	growth	growth	NN	B-NP
O	233	239	factor	factor	NN	I-NP
O	240	249	signaling	signaling	NN	I-NP
O	250	257	usually	usually	RB	B-ADVP
O	258	266	involves	involve	VBZ	B-VP
O	267	279	interactions	interaction	NNS	B-NP
O	280	284	with	with	IN	B-PP
O	285	288	the	the	DT	B-NP
O	289	296	heparan	heparan	NN	I-NP
O	297	304	sulfate	sulfate	NN	I-NP
O	305	311	chains	chain	NNS	I-NP
O	312	322	covalently	covalently	RB	B-VP
O	323	330	coupled	couple	VBN	I-VP
O	331	333	to	to	TO	B-PP
O	334	337	the	the	DT	B-NP
O	338	345	protein	protein	NN	I-NP
O	346	350	core	core	NN	I-NP
O	350	351	'	'	''	O
O	351	352	s	s	VBZ	B-VP
O	353	354	N	N	NN	B-NP
O	354	355	-	-	HYPH	I-NP
O	355	363	terminus	terminus	NN	I-NP
O	363	364	.	.	.	O

O	365	372	However	However	RB	B-ADVP
O	372	373	,	,	,	O
O	374	378	this	this	DT	B-NP
O	379	386	modular	modular	JJ	I-NP
O	387	394	protein	protein	NN	I-NP
O	395	399	core	core	NN	I-NP
O	400	404	also	also	RB	B-ADVP
O	405	410	binds	bind	VBZ	B-VP
O	411	415	with	with	IN	B-PP
O	416	426	relatively	relatively	RB	B-NP
O	427	431	high	high	JJ	I-NP
O	432	440	affinity	affinity	NN	I-NP
O	441	443	to	to	TO	B-PP
O	444	445	a	a	DT	B-NP
O	446	452	number	number	NN	I-NP
O	453	455	of	of	IN	B-PP
O	456	462	growth	growth	NN	B-NP
O	463	470	factors	factor	NNS	I-NP
O	471	474	and	and	CC	O
B-Cellular_component	475	482	surface	surface	NN	B-NP
O	483	492	receptors	receptor	NNS	I-NP
O	492	493	,	,	,	O
O	494	501	thereby	thereby	RB	B-VP
O	502	513	stabilizing	stabilize	VBG	I-VP
B-Cell	514	518	cell	cell	NN	B-NP
O	518	519	-	-	HYPH	I-NP
B-Cellular_component	519	525	matrix	matrix	NN	I-NP
O	526	531	links	link	NNS	I-NP
O	531	532	.	.	.	O

O	533	537	This	This	DT	B-NP
O	538	544	review	review	NN	I-NP
O	545	549	will	will	MD	B-VP
O	550	555	focus	focus	VB	I-VP
O	556	558	on	on	IN	B-PP
O	559	567	perlecan	perlecan	NN	B-NP
O	567	568	-	-	HYPH	B-NP
O	568	574	growth	growth	NN	I-NP
O	575	581	factor	factor	NN	I-NP
O	582	594	interactions	interaction	NNS	I-NP
O	595	598	and	and	CC	O
O	599	607	describe	describe	VBP	B-VP
O	608	614	recent	recent	JJ	B-NP
O	615	623	advances	advance	NNS	I-NP
O	624	626	in	in	IN	B-PP
O	627	630	our	our	PRP$	B-NP
O	631	644	understanding	understanding	NN	I-NP
O	645	647	of	of	IN	B-PP
O	648	652	this	this	DT	B-NP
O	653	659	highly	highly	RB	I-NP
O	660	669	conserved	conserve	VBN	I-NP
O	670	682	proteoglycan	proteoglycan	NN	I-NP
O	683	689	during	during	IN	B-PP
O	690	701	development	development	NN	B-NP
O	701	702	,	,	,	O
B-Cancer	703	709	cancer	cancer	NN	B-NP
O	710	716	growth	growth	NN	I-NP
O	716	717	,	,	,	O
O	718	721	and	and	CC	O
O	722	734	angiogenesis	angiogenesis	NN	B-NP
O	734	735	.	.	.	O

O	736	739	The	The	DT	B-NP
O	740	743	pro	pro	AFX	I-NP
O	743	744	-	-	HYPH	I-NP
O	744	754	angiogenic	angiogenic	JJ	I-NP
O	755	765	capacities	capacity	NNS	I-NP
O	766	768	of	of	IN	B-PP
O	769	777	perlecan	perlecan	NN	B-NP
O	778	782	that	that	WDT	B-NP
O	783	790	involve	involve	VBP	B-VP
O	791	804	proliferative	proliferative	JJ	B-NP
O	805	808	and	and	CC	I-NP
O	809	818	migratory	migratory	JJ	I-NP
O	819	826	signals	signal	NNS	I-NP
O	827	829	in	in	IN	B-PP
O	830	838	response	response	NN	B-NP
O	839	841	to	to	TO	B-VP
O	842	847	bound	bound	VB	I-VP
O	848	854	growth	growth	NN	B-NP
O	855	862	factors	factor	NNS	I-NP
O	863	867	will	will	MD	B-VP
O	868	870	be	be	VB	I-VP
O	871	879	explored	explore	VBN	I-VP
O	879	880	,	,	,	O
O	881	883	as	as	RB	B-CONJP
O	884	888	well	well	RB	I-CONJP
O	889	891	as	as	IN	I-CONJP
O	892	895	the	the	DT	B-NP
O	896	900	anti	anti	AFX	I-NP
O	900	901	-	-	HYPH	I-NP
O	901	911	angiogenic	angiogenic	JJ	I-NP
O	912	919	signals	signal	NNS	I-NP
O	920	929	resulting	result	VBG	B-VP
O	930	934	from	from	IN	B-PP
O	935	947	interactions	interaction	NNS	B-NP
O	948	955	between	between	IN	B-PP
O	956	959	the	the	DT	B-NP
O	960	961	C	C	NN	I-NP
O	961	962	-	-	HYPH	B-NP
O	962	970	terminal	terminal	JJ	I-NP
O	971	977	domain	domain	NN	I-NP
O	978	983	known	know	VBN	B-VP
O	984	986	as	as	IN	B-PP
O	987	999	endorepellin	endorepellin	NN	B-NP
O	1000	1003	and	and	CC	I-NP
O	1004	1013	integrins	integrin	NNS	I-NP
O	1014	1018	that	that	WDT	B-NP
O	1019	1026	control	control	VBP	B-VP
O	1027	1035	adhesion	adhesion	NN	B-NP
O	1036	1038	of	of	IN	B-PP
B-Cell	1039	1044	cells	cell	NNS	B-NP
O	1045	1047	to	to	TO	B-PP
O	1048	1051	the	the	DT	B-NP
B-Cellular_component	1052	1065	extracellular	extracellular	JJ	I-NP
I-Cellular_component	1066	1072	matrix	matrix	NN	I-NP
O	1072	1073	.	.	.	O

O	1074	1079	These	These	DT	B-NP
O	1080	1083	two	two	CD	I-NP
O	1084	1092	somewhat	somewhat	RB	I-NP
O	1093	1106	diametrically	diametrically	RB	I-NP
O	1107	1114	opposed	oppose	VBN	I-NP
O	1115	1120	roles	role	NNS	I-NP
O	1121	1125	will	will	MD	B-VP
O	1126	1128	be	be	VB	I-VP
O	1129	1138	discussed	discuss	VBN	I-VP
O	1139	1141	in	in	IN	B-PP
O	1142	1147	light	light	NN	B-NP
O	1148	1150	of	of	IN	B-PP
O	1151	1154	new	new	JJ	B-NP
O	1155	1159	data	datum	NNS	I-NP
O	1160	1168	emerging	emerge	VBG	B-VP
O	1169	1173	from	from	IN	B-PP
O	1174	1181	various	various	JJ	B-NP
O	1182	1188	fields	field	NNS	I-NP
O	1189	1194	which	which	WDT	B-NP
O	1195	1203	converge	converge	VBP	B-VP
O	1204	1206	on	on	IN	B-PP
O	1207	1215	perlecan	perlecan	NN	B-NP
O	1216	1218	as	as	IN	B-PP
O	1219	1220	a	a	DT	B-NP
O	1221	1224	key	key	JJ	I-NP
O	1225	1234	regulator	regulator	NN	I-NP
O	1235	1237	of	of	IN	B-PP
B-Cell	1238	1242	cell	cell	NN	B-NP
O	1243	1249	growth	growth	NN	I-NP
O	1250	1253	and	and	CC	I-NP
O	1254	1266	angiogenesis	angiogenesis	NN	I-NP
O	1266	1267	.	.	.	O

